Advertisement
U.S. Markets open in 6 hrs 47 mins
S&P Futures
5,882.75 -13.50 (-0.23%) Dow Futures
43,100.00 -77.00 (-0.18%) Nasdaq Futures
20,450.50 -69.00 (-0.34%) Russell 2000 Futures
2,247.40 -8.10 (-0.36%) Crude Oil
70.50 -0.06 (-0.09%) Gold
2,748.90 +10.00 (+0.37%)
Intellia Therapeutics, Inc. (38I.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Follow
As of 08:03AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 1.98B |
| Enterprise Value | 1.44B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 42.00 |
| Price/Book (mrq) | 2.17 |
| Enterprise Value/Revenue | 33.86 |
| Enterprise Value/EBITDA | -5.11 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.76 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 31.78 |
| 52 Week Low 3 | 15.48 |
| 50-Day Moving Average 3 | 18.94 |
| 200-Day Moving Average 3 | 22.28 |
Share Statistics
| Avg Vol (3 month) 3 | 214 |
| Avg Vol (10 day) 3 | 141 |
| Shares Outstanding 5 | 101.58M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 100.3M |
| % Held by Insiders 1 | 1.21% |
| % Held by Institutions 1 | 87.37% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,998.61% |
Management Effectiveness
| Return on Assets (ttm) | -26.05% |
| Return on Equity (ttm) | -49.02% |
Income Statement
| Revenue (ttm) | 45.97M |
| Revenue Per Share (ttm) | 0.50 |
| Quarterly Revenue Growth (yoy) | -48.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -514.18M |
| Net Income Avi to Common (ttm) | -508.8M |
| Diluted EPS (ttm) | -5.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 691.07M |
| Total Cash Per Share (mrq) | 6.8 |
| Total Debt (mrq) | 106.3M |
| Total Debt/Equity (mrq) | 10.95 |
| Current Ratio (mrq) | 7.20 |
| Book Value Per Share (mrq) | 9.88 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -373.28M |
| Levered Free Cash Flow (ttm) | -213.18M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.